Skip to Content

641 Results Found

  • Article
  • Open Access
13 Citations
3,524 Views
13 Pages

Diagnostic Utility of Cytomegalovirus (CMV) DNA Quantitation in Ulcerative Colitis

  • Sema Esen,
  • Imran Saglik,
  • Enver Dolar,
  • Selcan Cesur,
  • Nesrin Ugras,
  • Harun Agca,
  • Osman Merdan and
  • Beyza Ener

26 April 2024

Cytomegalovirus (CMV) colitis is a critical condition associated with severe complications in ulcerative colitis (UC). This study aimed to investigate the diagnostic value of the presence of CMV DNA in intestinal mucosa tissue and blood samples in pa...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Review
  • Open Access
38 Citations
10,411 Views
15 Pages

Cytomegalovirus (CMV) Pneumonitis: Cell Tropism, Inflammation, and Immunity

  • Luís Fonseca Brito,
  • Wolfram Brune and
  • Felix R. Stahl

Human cytomegalovirus (HCMV) is an opportunistic pathogen causing disease mainly in immunocompromised patients or after congenital infection. HCMV infection of the respiratory tract leads to pneumonitis in the immunocompromised host, which is often a...

(This article belongs to the Special Issue Lung Infections: From Molecular Biology to Therapy)
  • Article
  • Open Access
15 Citations
11,265 Views
16 Pages

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease

  • Tobias M. Nowacki,
  • Dominik Bettenworth,
  • Matthias Ross,
  • Jan Heidemann,
  • Paul V. Lehmann and
  • Andreas Lügering

23 April 2012

The role of cytomegalovirus (CMV) infection in the pathogenesis and exacerbation of Inflammatory Bowel Disease (IBD) has been unresolved. Typically, the CMV genome remains dormant in infected cells, but a breakdown of immune surveillance can lead to...

(This article belongs to the Special Issue ELISPOT Research)
  • Article
  • Open Access
8 Citations
3,508 Views
18 Pages

6 April 2022

Congenital cytomegalovirus (CMV) is a leading cause of disease in newborns and a vaccine is a high priority. The guinea pig is the only small animal model for congenital CMV but requires guinea pig cytomegalovirus (GPCMV). Previously, a disabled infe...

(This article belongs to the Special Issue Anti-herpesvirus Drugs and Vaccines)
  • Article
  • Open Access
12 Citations
7,299 Views
16 Pages

Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets

  • Fakhri Hassouneh,
  • Nelson Lopez-Sejas,
  • Carmen Campos,
  • Beatriz Sanchez-Correa,
  • Raquel Tarazona,
  • Alejandra Pera and
  • Rafael Solana

The differential impact of ageing and cytomegalovirus (CMV) latent infection on human T-cell subsets remains to some extent controversial. The purpose of this study was to analyse the expression of the transcription factors T-bet and Eomes and CD57 o...

(This article belongs to the Special Issue Immunology of Aging)
  • Article
  • Open Access
12 Citations
3,896 Views
15 Pages

Peptide Vaccination against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients

  • Claudia Sommerer,
  • Anita Schmitt,
  • Angela Hückelhoven-Krauss,
  • Thomas Giese,
  • Thomas Bruckner,
  • Lei Wang,
  • Paul Schnitzler,
  • Stefan Meuer,
  • Martin Zeier and
  • Michael Schmitt

6 February 2021

Introduction: Cytomegalovirus (CMV) reactivation occurs in seronegative patients after solid organ transplantation (SOT) particularly from seropositive donors and can be lethal. Generation of CMV-specific T cells helps to prevent CMV reactivation. Th...

(This article belongs to the Special Issue Advances in Vaccine Development and Immunotherapies)
  • Article
  • Open Access
1 Citations
3,654 Views
17 Pages

Cytomegalovirus (CMV) infections exert a substantial impact on the practice of pediatric infectious diseases. Although most infections in children are minimally symptomatic, several populations are at risk for CMV-associated disease, including immuno...

  • Article
  • Open Access
4 Citations
2,740 Views
14 Pages

The NFKB1 Promoter Polymorphism (-94ins/delATTG) Is Associated with Susceptibility to Cytomegalovirus Infection after Kidney Transplantation and Should Have Implications on CMV Prophylaxis Regimens

  • Hartmuth Nowak,
  • Svenja Vornweg,
  • Katharina Rump,
  • Tim Rahmel,
  • Matthias Unterberg,
  • Björn Koos,
  • Peter Schenker,
  • Richard Viebahn,
  • Michael Adamzik and
  • Lars Bergmann

12 February 2021

Infections with cytomegalovirus (CMV) are one of the most frequent opportunistic infections in kidney transplant recipients. Current risk-adapted CMV chemoprophylaxis regimens are based almost solely on the donor and recipient CMV serostatus. Of note...

(This article belongs to the Section Cellular Immunology)
  • Article
  • Open Access
28 Citations
3,635 Views
19 Pages

Clinical, Virologic and Immunologic Correlates of Breast Milk Acquired Cytomegalovirus (CMV) Infections in Very Low Birth Weight (VLBW) Infants in a Newborn Intensive Care Unit (NICU) Setting

  • Nelmary Hernandez-Alvarado,
  • Ryan Shanley,
  • Mark R. Schleiss,
  • Jensina Ericksen,
  • Jenna Wassenaar,
  • Lulua Webo,
  • Katherine Bodin,
  • Katelyn Parsons and
  • Erin A. Osterholm

22 September 2021

Cytomegalovirus (CMV) infections acquired by very-low-birthweight (VLBW) infants are incompletely characterized. To examine CMV transmission in VLBW infants, we evaluated maternal DNAlactia, infant DNAemia, and presence of clinical disease in a blind...

(This article belongs to the Special Issue Pediatric Viral Infection Long-Term Consequences)
  • Review
  • Open Access
10 Citations
4,905 Views
11 Pages

19 October 2023

Human Cytomegalovirus (HCMV) is a ubiquitous member of the Herpesviridae family, responsible for the most common congenital viral infection—congenital Cytomegalovirus (cCMV) infection. While a majority of HCMV infections in children and adults...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
1 Citations
2,083 Views
10 Pages

5 September 2025

Primary or recurrent infection of cytomegalovirus (CMV) in pregnant women may cause transplacental transmission to fetuses. We aimed to investigate the rate of transplacental CMV transmission in women with positive anti-CMV IgG and negative anti-CMV...

  • Editorial
  • Open Access
15 Citations
3,287 Views
4 Pages

14 September 2020

The congenital transmission of cytomegalovirus (cCMV) is the most common infectious cause of disability in children in the developed world, and probably globally [...]

(This article belongs to the Special Issue Cytomegalovirus Infection and Vaccine Development)
  • Case Report
  • Open Access
11 Citations
3,058 Views
11 Pages

Cytomegalovirus (CMV) infection is the most significant viral infection in hosts with compromised immune systems as solid organ transplant patients. Despite significant progress being made in the prevention of CMV disease in these patients, further t...

(This article belongs to the Section Medical Microbiology)
  • Article
  • Open Access
71 Citations
12,921 Views
24 Pages

The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review

  • Hassan Al Mana,
  • Hadi M. Yassine,
  • Nadin N. Younes,
  • Anjud Al-Mohannadi,
  • Duaa W. Al-Sadeq,
  • Dalal Alhababi,
  • Elham A. Nasser and
  • Gheyath K. Nasrallah

31 October 2019

Human cytomegalovirus (CMV) is a highly prevalent herpesvirus worldwide. According to the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), CMV infects people of all ages, and by the age of five, approximately...

(This article belongs to the Section Viral Pathogens)
  • Article
  • Open Access
5 Citations
3,949 Views
12 Pages

Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV

  • Lukas Bunse,
  • Claudia Sommerer,
  • Chin Leng Tan,
  • Felix Korell,
  • Anita Schmitt,
  • Angela Hückelhoven-Krauss,
  • Brigitte Neuber,
  • Thomas Mertens,
  • Michael Platten and
  • Michael Schmitt
  • + 2 authors

18 January 2022

After solid-organ transplantation, reactivation of the cytomegalovirus (CMV) is often observed in seronegative patients and associated with a high risk of disease and mortality. CMV-specific T cells can prevent CMV reactivation. In a phase 1 trial, C...

(This article belongs to the Special Issue Host-Cytomegalovirus Interactions: Pro- and Antiviral Key Factors Affecting CMV Infection Outcome or Therapeutic Approaches 3.0)
  • Review
  • Open Access
30 Citations
7,060 Views
17 Pages

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)

  • Samantha Barnes,
  • Ophelia Schilizzi,
  • Katherine M. Audsley,
  • Hannah V. Newnes and
  • Bree Foley

23 November 2020

Natural killer (NK) cells play a significant and vital role in the first line of defense against infection through their ability to target cells without prior sensitization. They also contribute significantly to the activation and recruitment of both...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
9 Citations
4,585 Views
14 Pages

Congenital cytomegalovirus (cCMV) infection is a leading cause of sensorineural hearing loss (SNHL) and neurodevelopmental disabilities in children worldwide. Some regions in the United States and Canada have implemented universal newborn screening f...

(This article belongs to the Special Issue Newborn Screening for Congenital CMV)
  • Case Report
  • Open Access
2 Citations
4,376 Views
6 Pages

Autoimmune Hemolytic Anemia (AIHA) Secondary to Cytomegalovirus (CMV) Infection in a 2-Month-Old Infant: A Case Report

  • Stefano Romano,
  • Giuseppe Pepe,
  • Ilaria Fotzi,
  • Tommaso Casini,
  • Elena Chiocca and
  • Sandra Trapani

7 December 2023

Autoimmune hemolytic anemia (AIHA) is a rare hematologic disorder in the pediatric population and most cases are associated with microbiological infection. The pathological process is not completely clear, but some evidence suggests immunological dys...

(This article belongs to the Section Pediatric Hematology & Oncology)
  • Article
  • Open Access
5 Citations
4,216 Views
10 Pages

A Qualitative Assessment of Clinical Practice Guidelines and Patterns for Congenital Cytomegalovirus in the United States

  • Stephanie Kalb,
  • John Diaz-Decaro,
  • Harout Tossonian,
  • Andrew Natenshon,
  • Lori Panther,
  • James Mansi and
  • Laura Gibson

Cytomegalovirus (CMV) infection during pregnancy may result in long-term health problems for children with congenital CMV (cCMV). Currently, no prevention or treatment interventions are approved by the Food and Drug Administration for a cCMV indicati...

(This article belongs to the Special Issue Newborn Screening for Congenital CMV)
  • Review
  • Open Access
4 Citations
3,868 Views
22 Pages

CMV Retinitis in the Context of SARS-CoV-2 Infection: A Case Study and Comprehensive Review of Viral Interactions

  • Emil Robert Stoicescu,
  • Laura Andreea Ghenciu,
  • Roxana Iacob,
  • Adina Iuliana Ardelean,
  • Ecaterina Dăescu,
  • Ovidiu Alin Hațegan,
  • Diana Manolescu,
  • Emanuela Tudorache,
  • Casiana Boru and
  • Mirabela Dima

29 October 2024

Purpose: Cytomegalovirus (CMV) retinitis is a sight-threatening condition predominantly affecting immunocompromised individuals, such as those with Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS). We aimed to present an o...

  • Conference Report
  • Open Access
4 Citations
1,662 Views
6 Pages

29 October 2024

Congenital cytomegalovirus (cCMV) is the most common infectious cause of disability in children. The major theme of this National Institute of Allergy and Infectious Diseases (NIAID) workshop, “CMV Vaccine Development—How Close Are We?&rd...

  • Conference Report
  • Open Access
13 Citations
4,485 Views
30 Pages

Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)

  • Mark R. Schleiss,
  • Chelsea M. Crooks,
  • Krithika P. Karthigeyan,
  • Rebecca M. Kruc,
  • Claire E. Otero,
  • Hsuan-Yuan (Sherry) Wang,
  • Sallie R. Permar,
  • Stanley A. Plotkin and
  • Rajeev Gautam

29 October 2024

Congenital cytomegalovirus (cCMV) is the most common infectious cause of disability in children, including sensorineural hearing loss. There is interest in developing a pre-conception vaccine that could confer protective immunity on a woman of child-...

  • Case Report
  • Open Access
1 Views
2 Pages

29 November 2011

In immunocompetent hosts, symptomatic cytomegalovirus (CMV) infection occurs in around 10% and has traditionally been considered to have a benign, self-limiting course. Active CMV infection in immunocompetent persons is very rare. However, manifestat...

  • Review
  • Open Access
72 Citations
10,379 Views
18 Pages

Cytomegalovirus Infection and Inflammation in Developing Brain

  • Fran Krstanović,
  • William J. Britt,
  • Stipan Jonjić and
  • Ilija Brizić

4 June 2021

Human cytomegalovirus (HCMV) is a highly prevalent herpesvirus that can cause severe disease in immunocompromised individuals and immunologically immature fetuses and newborns. Most infected newborns are able to resolve the infection without developi...

(This article belongs to the Special Issue State-of-the-Art Virology Research in Croatia)
  • Article
  • Open Access
1,895 Views
12 Pages

Vitamin D Status, CMV Seropositivity, and Viral Cytokine Expression in Pregnancy

  • Adalvan D. Martins,
  • Jennifer Woo,
  • Brandi Falley and
  • Juliet V. Spencer

31 August 2025

Cytomegalovirus (CMV) is the leading infectious cause of birth defects and has been linked to increased risk of preterm birth (PTB). CMV establishes lifelong latency and is more prevalent among Black and Hispanic/Latina women, populations already at...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Article
  • Open Access
1 Citations
1,474 Views
16 Pages

Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48

  • Carlos Fierro,
  • Daniel Brune,
  • Richard Leggett,
  • James Peterson,
  • Benjamin Lorenz,
  • Renato Calabro Calheiros,
  • Jiang Lin,
  • Anita S. Iyer,
  • Kai Wu and
  • Lori Panther
  • + 5 authors

Background/Objectives: No licensed vaccine against cytomegalovirus (CMV) is currently available, despite the significant risk of mother-to-infant transmission leading to serious neurodevelopmental impairment and the substantial morbidity caused by CM...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Review
  • Open Access
4 Citations
2,329 Views
20 Pages

Cytomegaloviruses (CMVs) encode viral G-protein-coupled receptors (vGPCRs) that have diverged from their cellular homologues to perform new functions. Human cytomegalovirus (HCMV) encodes four vGPCRs: UL33, UL78, US27, and US28, which contribute to v...

(This article belongs to the Special Issue Understanding Human Cytomegalovirus Pathogenesis: Evidence from the Clinic and Laboratory Models)
  • Article
  • Open Access
9 Citations
3,786 Views
12 Pages

27 September 2022

Background: Cytomegalovirus (CMV) is a deoxyribonucleic acid virus that affects a significant proportion of the worldwide population; after primary infection, it goes into a latent state and can be reactivated, primarily after a reduction in host imm...

  • Article
  • Open Access
10 Citations
4,480 Views
14 Pages

Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area

  • Tsung-Jang Yeh,
  • Ching-I Yang,
  • Chien-Tzu Huang,
  • Min-Hung Wang,
  • Tzer-Ming Chuang,
  • Ya-Lun Ke,
  • Yuh-Ching Gau,
  • Jeng-Shiun Du,
  • Hui-Ching Wang and
  • Yi-Chang Liu
  • + 4 authors

16 April 2022

Infection is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT) especially cytomegalovirus (CMV) infection and invasive fungal infection (IFI). Taiwan is a high CMV seroprevalence area. Our study aimed to evalua...

(This article belongs to the Special Issue When Viruses and Fungi Act Together)
  • Article
  • Open Access
21 Citations
4,936 Views
11 Pages

19 November 2022

Viral infections, or their reactivations, are one of the most important groups of transplantation complications that can occur among recipients of both hematopoietic cells and solid organ transplants. They are the most commonly caused by cytomegalovi...

(This article belongs to the Special Issue Pathogenesis of Human Cytomegalovirus Infection)
  • Review
  • Open Access
15 Citations
6,291 Views
17 Pages

Exploring the Potential of Cytomegalovirus-Based Vectors: A Review

  • Janine Zeng,
  • Dabbu Kumar Jaijyan,
  • Shaomin Yang,
  • Shaokai Pei,
  • Qiyi Tang and
  • Hua Zhu

2 October 2023

Viral vectors have emerged as powerful tools for delivering and expressing foreign genes, playing a pivotal role in gene therapy. Among these vectors, cytomegalovirus (CMV) stands out as a promising viral vector due to its distinctive attributes incl...

(This article belongs to the Special Issue 65-Year Anniversary of the Discovery of Cytomegalovirus)
  • Article
  • Open Access
15 Citations
5,439 Views
20 Pages

27 July 2021

A vaccine against congenital cytomegalovirus infection is a high priority. Guinea pig cytomegalovirus (GPCMV) is the only congenital CMV small animal model. GPCMV encodes essential glycoprotein complexes for virus entry (gB, gH/gL/gO, gM/gN) includin...

(This article belongs to the Special Issue Cytomegalovirus Immunity 2021)
  • Article
  • Open Access
3 Citations
2,462 Views
10 Pages

Transient Decrease in Incidence Rate of Maternal Primary Cytomegalovirus Infection during the COVID-19 Pandemic in Japan

  • Kuniaki Toriyabe,
  • Asa Kitamura,
  • Miki Hagimoto-Akasaka,
  • Makoto Ikejiri,
  • Shigeru Suga,
  • Eiji Kondo,
  • Masamichi Kihira,
  • Fumihiro Morikawa and
  • Tomoaki Ikeda

29 April 2023

This study evaluated the impact of the coronavirus disease 2019 (COVID-19) pandemic on the occurrence of maternal primary cytomegalovirus (CMV) infection in Japan. We performed a nested case-control study using data from maternal CMV antibody screeni...

(This article belongs to the Special Issue Congenital Cytomegalovirus Infection)
  • Article
  • Open Access
10 Citations
4,233 Views
17 Pages

20 August 2020

The guinea pig is the only small animal model for congenital cytomegalovirus (cCMV) but requires guinea pig cytomegalovirus (GPCMV). Current GPCMV research utilizes prototype strain 22122, which limits the translational impact of GPCMV as numerous hu...

(This article belongs to the Special Issue Host-Cytomegalovirus Interactions: Pro- and Antiviral Key Factors Affecting CMV Infection Outcome or Therapeutic Approaches 2.0)
  • Article
  • Open Access
4 Citations
4,641 Views
14 Pages

Evaluation of Two Different CMV-Immunoglobulin Regimens for Combined CMV Prophylaxis in High-Risk Patients following Lung Transplant

  • Víctor M. Mora,
  • Piedad Ussetti,
  • Alicia de Pablo,
  • David Iturbe,
  • Rosalía Laporta,
  • Rodrigo Alonso,
  • Myriam Aguilar,
  • Carlos A. Quezada and
  • José M. Cifrián

Background: The clinical benefits of the common off-label use of cytomegalovirus (CMV)-specific immunoglobulin (CMV-Ig) combined with antivirals in organ transplantation have not been previously assessed. The objective was to compare the risk of CMV...

(This article belongs to the Special Issue Infectious Diseases in Organ Transplantation)
  • Systematic Review
  • Open Access
20 Citations
5,869 Views
13 Pages

2 March 2022

Cytomegalovirus (CMV) is a common infection occurring in patients undergoing solid organ transplantation (SOT) or hematopoietic stem cell transplantation (HSCT). CMV-specific hyperimmunoglobulin (CMVIG) has been used for the past four decades and is...

(This article belongs to the Section Medical Research)
  • Article
  • Open Access
5 Citations
3,615 Views
8 Pages

Congenital CMV, Lights and Shadows on Its Management: The Experience of a Reference Center in Northern Italy

  • Valeria Rubinacci,
  • Mara Fumagalli,
  • Giulia Meraviglia,
  • Laura Gianolio,
  • Anna Sala,
  • Marta Stracuzzi,
  • Anna Dighera,
  • Gian Vincenzo Zuccotti and
  • Vania Giacomet

Congenital cytomegalovirus infection (cCMV) is the most common congenital viral infection, with a consistent rate of morbidity, mortality, and long-term sequelae, especially in the case of late diagnosis. Nevertheless, a universal screening for CMV i...

(This article belongs to the Special Issue Updates in Congenital Infections: Pathology, Diagnosis, Management and Outcomes)
  • Article
  • Open Access
5 Citations
1,169 Views
13 Pages

Antenatal Imaging and Neonatal Outcome in Infants with Congenital Cytomegalovirus Infection: The Effect of Valaciclovir

  • Francesca Arcieri,
  • Adele Vasta,
  • Sara Sorrenti,
  • Gregorio Volpe,
  • Valentina D’Ambrosio,
  • Daniele Di Mascio,
  • Fabio Natale,
  • Lucia Manganaro,
  • Giuseppina Liuzzi and
  • Antonella Giancotti
  • + 5 authors

19 January 2026

Background: Congenital cytomegalovirus (cCMV) infection is a leading cause of neonatal morbidity. This retrospective study aimed to evaluate the efficacy of valacyclovir in reducing vertical transmission after primary maternal CMV infection and to as...

(This article belongs to the Section Obstetrics & Gynecology)
  • Case Report
  • Open Access
27 Citations
15,407 Views
17 Pages

Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial

  • Larry R. Smith,
  • Mary K. Wloch,
  • Jennifer A. Chaplin,
  • Michele Gerber and
  • Alain P. Rolland

25 September 2013

2013 marks a milestone year for plasmid DNA vaccine development as a first-in-class cytomegalovirus (CMV) DNA vaccine enters pivotal phase 3 testing. This vaccine consists of two plasmids expressing CMV antigens glycoprotein B (gB) and phosphoprotei...

(This article belongs to the Special Issue DNA Vaccines)
  • Article
  • Open Access
2 Citations
2,670 Views
10 Pages

Susceptibility of Mouse Brain to MCMV Infection and Neuroinflammation During Ontogeny

  • Fran Krstanović,
  • Andrea Mihalić,
  • Lucija Šakota,
  • Berislav Lisnić,
  • Stipan Jonjić and
  • Ilija Brizić

14 December 2024

Human cytomegalovirus (HCMV) rarely infects the brain following infection of adult individuals. However, the virus readily infects the brain during congenital HCMV (cHCMV) infection, frequently causing severe neurodevelopmental and neurological seque...

(This article belongs to the Special Issue Understanding Human Cytomegalovirus Pathogenesis: Evidence from the Clinic and Laboratory Models)
  • Review
  • Open Access
5 Citations
4,219 Views
11 Pages

Cytomegalovirus (CMV) reactivation in patients with autoimmune bullous disease (AIBD) or severe drug eruption treated with immunosuppressive therapy was traditionally thought to be merely an epiphenomenon of the underlying immunosuppression. However,...

(This article belongs to the Special Issue Antiviral Drugs 2021)
  • Review
  • Open Access
19 Citations
5,481 Views
12 Pages

Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV

  • Léna Royston,
  • Stéphane Isnard,
  • John Lin and
  • Jean-Pierre Routy

29 June 2021

In stark contrast to the rapid development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an effective human immunodeficiency virus (HIV) vaccine is still lacking. Furthermore, despite virologic suppression and CD4...

(This article belongs to the Special Issue HIV and SARS-CoV-2 Pathogenesis and Vaccine Development)
  • Communication
  • Open Access
4 Citations
3,443 Views
18 Pages

24 August 2022

Cytomegalovirus (CMV) syndrome and infectious disease are defined as pathogen detection with appropriate clinical symptoms, but there are not pathognomonic signs of CMV disease. Although the prodrome of acute minor viral infections leukopenia (lympho...

(This article belongs to the Special Issue Virus Replication)
  • Communication
  • Open Access
10 Citations
6,652 Views
14 Pages

Although the existing paradigm states that cytomegalovirus (CMV) reactivation is under the control of the cellular immune response, the role of humoral and innate counterparts are underestimated. The study analyzed the host–virus interaction i.e., CM...

(This article belongs to the Special Issue Host-Cytomegalovirus Interactions: Pro- and Antiviral Key Factors Affecting CMV Infection Outcome or Therapeutic Approaches)
  • Article
  • Open Access
31 Citations
4,150 Views
13 Pages

Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study

  • Léna Royston,
  • Eva Royston,
  • Stavroula Masouridi-Levrat,
  • Nathalie Vernaz,
  • Yves Chalandon,
  • Christian Van Delden and
  • Dionysios Neofytos

12 April 2021

Background: Real-life data on the administration of letermovir as cytomegalovirus (CMV) primary prophylaxis after allogeneic hematopoietic cell transplantation (HCT) remain limited. Methods: We conducted a retrospective single-center matched cohort s...

  • Review
  • Open Access
3 Citations
3,203 Views
8 Pages

Cytomegalovirus Seropositivity and Suicidal Behavior: A Mini-Review

  • Marco Paolini,
  • David Lester,
  • Michael Hawkins,
  • Ameth Hawkins-Villarreal,
  • Denise Erbuto,
  • Andrea Fiorillo and
  • Maurizio Pompili

12 December 2019

Background and objectives: In recent years, a growing body of research has focused on identifying possible biological markers for suicidal behavior, including infective and immunological markers. In this paper, our aim was to review available evidenc...

(This article belongs to the Special Issue Preventing Suicide in Patients with Mental Disorders)
  • Case Report
  • Open Access
7 Citations
3,397 Views
5 Pages

A New Viral Coinfection: SARS-CoV-2 Pneumonia and Cytomegalovirus Pneumonitis in a Renal Transplant Recipient

  • Abdullah S. Shaikh,
  • Hila Shaim,
  • Maria A. Caravedo,
  • Karen M. Ong and
  • David Reynoso

7 July 2021

SARS-CoV-2 has caused a global pandemic of an acute respiratory illness known as COVID-19. Patients with solid organ transplants receiving chronic immunosuppressive therapy are at risk of severe disease caused by opportunistic pathogens, including cy...

  • Case Report
  • Open Access
1 Citations
1,437 Views
11 Pages

Refractory CMV Enteritis in Small Bowel Transplantation: A Case Highlighting the Challenges of Balancing Immunosuppression and Novel Antiviral Therapies

  • Abdulrahman A. Al-Saud,
  • Ehab H. Abufarhaneh,
  • Madain S. Alsanea,
  • Reem M. Alameer,
  • Amani H. Yamani,
  • Fatimah S. Alhamlan and
  • Reem S. Almaghrabi

15 October 2025

Background: Cytomegalovirus (CMV) remains a formidable complication in small bowel transplantation (SBT) due to the graft’s high immunogenicity and profound immunosuppression required, with refractory disease representing a particularly devasta...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Review
  • Open Access
2 Citations
3,035 Views
27 Pages

Postnatally Acquired Neonatal CMV Infection in Preterm Infants: From a Case Series to a Narrative Review of the Literature

  • Serena Salomè,
  • Ida D’Acunzo,
  • Clara Coppola,
  • Giovanna Montesano,
  • Gaetano Ausanio,
  • Angela Umbaldo,
  • Fiorella Migliaro,
  • Letizia Capasso and
  • Francesco Raimondi

29 December 2025

Background: Postnatal cytomegalovirus (pCMV) infection is a frequent viral condition in early infancy and is primarily acquired through maternal breastfeeding. Although usually asymptomatic in term infants, it can lead to significant morbidity in pre...

(This article belongs to the Section Pediatric Infectious Diseases)

of 13